American Journal of Epidemiology · Nov 19, 2026
The influence of pre-diagnostic allostatic load on mortality after incident colorectal cancer
By Walts Z, Ogunmuyiwa O, Cochran A et al.
Allostatic load is an emerging stress biomarker capturing immune, cardiovascular, and metabolic dysregulations. We evaluated associations between allostatic load and mortality after colorectal cancer (CRC) diagnosis, comparing allostatic load to metabolic syndrome to determine if including additional domains beyond metabolism strengthens associations with mortality. Southern Community Cohort Study participants who developed incident CRC after enrollment (2002-2009) were included; most self-identified as Black (69%) and report <$15,000 annual household income (55%). Enrollment samples were analyzed for immune, metabolic, and cardiovascular biomarkers. A standard metabolic syndrome definition was used (3/5 traits); most (N=1007) had available information to calculate metabolic syndrome. To calculate allostatic load, biomarkers above clinical risk cutoffs were summed; counts above median indicated high allostatic load (4/10 traits). A subsample of 303 had additional information to calculate allostatic load. Mortality was ascertained through 2020 via National Death Index linkage. Multivariate-adjusted Cox models estimated hazard ratios and 95% confidence intervals (HR[95%CI]). High allostatic load was associated with higher risk of all-cause (1.81[1.25-2.62]) and CRC-specific mortality (HR:1.81[1.07-3.07]). The latter attenuated after controlling for health behaviors (HR:1.57[0.91-2.70]). Metabolic syndrome was not associated with mortality (all-cause: 1.06[0.88-1.28]; CRC-specific: 1.08[0.83-1.40]). Allostatic load may be a clinically actionable biomarker to readily identify cancer patients with comorbidity.